Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of Physicians

ACP has issued an update of its guideline with clinical recommendations for nonpharmacologic and pharmacologic treatments of adults in the acute phase of major depressive disorder (MDD). In the updated clinical guideline, ACP recommends the use of either cognitive behavioral therapy (CBT) or second-generation antidepressants (SGAs) as initial treatment in adults with moderate to severe MDD, and suggests the combination of both, as an alternate initial treatment option.

Andrew Hachadorian

cognitive behavioral therapy, second-generation antidepressants, major depressive disorder, nonpharmacologic, pharmacologic, depression, monotherapy

Tue, 01/24/2023 - 9:47 AM EST

Tue, 01/24/2023 - 10:12 AM EST

1

nonpharmacologic_and_pharmacologic_treatments_of_adults_in_the_acute_phase_of_major_depressive_disorder_2023.pdf

{"Author":"Andrew Hachadorian","Creator":"Microsoft\u00ae Word for Microsoft 365","CreationDate":"2023-01-24T09:47:10-05:00","ModDate":"2023-01-24T10:12:37-05:00","Producer":"Microsoft\u00ae Word for Microsoft 365","Title":"Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of Physicians","Subject":"","Keywords":"cognitive behavioral therapy, second-generation antidepressants, major depressive disorder, nonpharmacologic, pharmacologic, depression, monotherapy","Pages":1}

2023